New, shorter TB treatments could advance TB control

The current recommended treatment for TB is to give four or more antibiotics for at least six months (this treatment is called “DOTS” or Directly Observed Therapy Short Course–but few patients would agree that taking drugs for 6 months is indeed a “short” course). New TB treatments are currently being tested, and it looks like some of them might be effective when taken for shorter periods. Joshua Salomon (Harvard School of Public Health) and colleagues used a mathematical model to predict what would happen if, instead of having to give a 6-month course, TB could be cured with just a 2-month course of antibiotics.

In Salomon and colleagues’ model, a 2-month course led to a quicker fall in the number of new cases of TB each year compared with a 6-month course. Patients who fail to finish a course of treatment can infect others, and it is less likely for patients to drop out of a 2-month course than a 6-month course.

The researchers applied their model to South-East Asia, a region where DOTS is being scaled up and where one-third of all new TB cases occur. They found that even if DOTS is scaled up as planned, a 2-month drug course would still reduce new TB cases and deaths much quicker than a 6-month course.

If, for example, a 2-month drug treatment were introduced by 2012, it might prevent 13% of the new cases and 19% of the TB deaths that would otherwise occur in South-East Asia between 2012 and 2030.

These benefits might be even greater if the new, shorter course treatment freed up financial and human resources to improve efforts to detect new TB cases. On the other hand, delaying its implementation until 2022 would erase three-quarters of the predicted benefits.

Like all mathematical models, this new one makes many assumptions—including the assumption that the experimental TB drugs that are currently being tested can indeed cure TB in 2 months. Nevertheless, Salomon and colleagues’ work suggests that the impact of DOTS could be improved by using shorter treatment courses.

Media Contact

Andrew Hyde alfa

More Information:

http://www.plosmedicine.org

All latest news from the category: Health and Medicine

This subject area encompasses research and studies in the field of human medicine.

Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.

Back to home

Comments (0)

Write a comment

Newest articles

A universal framework for spatial biology

SpatialData is a freely accessible tool to unify and integrate data from different omics technologies accounting for spatial information, which can provide holistic insights into health and disease. Biological processes…

How complex biological processes arise

A $20 million grant from the U.S. National Science Foundation (NSF) will support the establishment and operation of the National Synthesis Center for Emergence in the Molecular and Cellular Sciences (NCEMS) at…

Airborne single-photon lidar system achieves high-resolution 3D imaging

Compact, low-power system opens doors for photon-efficient drone and satellite-based environmental monitoring and mapping. Researchers have developed a compact and lightweight single-photon airborne lidar system that can acquire high-resolution 3D…

Partners & Sponsors